Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Islet inflammation in type 2 diabetes: from metabolic stress to therapy Donath MY; Schumann DM; Faulenbach M; Ellingsgaard H; Perren A; Ehses JADiabetes Care 2008[Feb]; 31 Suppl 2 (ä): S161-4Decreases in both mass and secretory function of insulin-producing beta-cells contribute to the pathophysiology of type 2 diabetes. The histology of islets from patients with type 2 diabetes displays an inflammatory process characterized by the presence of cytokines, apoptotic cells, immune cell infiltration, amyloid deposits, and eventually fibrosis. This inflammatory process is probably the combined consequence of dyslipidemia, hyperglycemia, and increased circulating adipokines. Therefore, modulation of intra-islet inflammatory mediators, in particular interleukin-1 beta, appears as a promising therapeutic approach.|Cytokines/physiology[MESH]|Diabetes Mellitus, Type 2/*complications/drug therapy/metabolism/*physiopathology[MESH]|Dyslipidemias/etiology[MESH]|Glucose/pharmacology[MESH]|Humans[MESH]|Hypoglycemic Agents/therapeutic use[MESH]|Inflammation/chemically induced/epidemiology/*physiopathology[MESH]|Insulin-Secreting Cells/drug effects/pathology/physiology[MESH]|Interleukin-1beta/physiology[MESH]|Islets of Langerhans/immunology[MESH]|Leptin/blood[MESH]|Obesity/epidemiology[MESH]|Pancreatic Diseases/*physiopathology[MESH] |